Jennifer Freeland

Jennifer Freeland is a seasoned professional in the field of biotechnology and histology, currently serving as a Senior Clinical Content Writer at Agilent Technologies since December 2020. With a robust background that includes roles as Global Market Development Manager at Epredia and Market Development Manager at Thermo Fisher Scientific, notable expertise encompasses quality control procedures compliant with ISO 13485, development of stability programs, and management of R&D initiatives. Jennifer's career highlights also feature significant contributions as a Technical Consultant at Richard-Allan Scientific and various positions within Allegiance Healthcare and MPI Research, showcasing extensive knowledge in immunohistochemistry and histology. Jennifer holds a Master's degree in Biotechnology from Johns Hopkins University and a BS in Biomedical Science from Western Michigan University.